CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 159 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $20,661,000 | +57.2% | 611,273 | +8.8% | 0.00% | +50.0% |
Q1 2021 | $13,141,000 | -8.4% | 561,845 | +12.8% | 0.00% | 0.0% |
Q4 2020 | $14,348,000 | +55.0% | 498,208 | +9.0% | 0.00% | 0.0% |
Q3 2020 | $9,258,000 | -20.8% | 457,004 | +17.5% | 0.00% | -33.3% |
Q2 2020 | $11,688,000 | +30.1% | 388,968 | +36.1% | 0.00% | +50.0% |
Q1 2020 | $8,982,000 | -57.9% | 285,789 | -36.9% | 0.00% | 0.0% |
Q4 2019 | $21,322,000 | +2950.4% | 452,654 | +317.9% | 0.00% | – |
Q3 2019 | $699,000 | -45.9% | 108,318 | +2.9% | 0.00% | – |
Q2 2019 | $1,292,000 | +6.5% | 105,234 | +17.5% | 0.00% | – |
Q1 2019 | $1,213,000 | +1002.7% | 89,587 | +226.1% | 0.00% | – |
Q4 2018 | $110,000 | +39.2% | 27,470 | +133.8% | 0.00% | – |
Q3 2018 | $79,000 | – | 11,748 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |